Varian Medical Systems, Inc. (NYSE:VAR) EVP Kolleen T. Kennedy Sells 1,088 Shares

Varian Medical Systems, Inc. (NYSE:VAR) EVP Kolleen T. Kennedy sold 1,088 shares of Varian Medical Systems stock in a transaction dated Wednesday, July 12th. The stock was sold at an average price of $104.49, for a total value of $113,685.12. Following the sale, the executive vice president now owns 27,688 shares of the company’s stock, valued at approximately $2,893,119.12. The transaction was disclosed in a document filed with the SEC, which is available at this link.

Varian Medical Systems, Inc. (VAR) opened at 95.88 on Wednesday. Varian Medical Systems, Inc. has a 52 week low of $75.20 and a 52 week high of $107.08. The company’s 50-day moving average price is $102.77 and its 200-day moving average price is $92.76. The company has a market capitalization of $8.79 billion, a P/E ratio of 31.56 and a beta of 0.61.

Varian Medical Systems (NYSE:VAR) last issued its quarterly earnings results on Wednesday, July 26th. The medical equipment provider reported $1.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.95 by $0.09. The business had revenue of $662.40 million during the quarter, compared to analysts’ expectations of $663.86 million. Varian Medical Systems had a return on equity of 24.70% and a net margin of 9.50%. The firm’s revenue for the quarter was up 3.0% compared to the same quarter last year. During the same period in the previous year, the company posted $1.00 earnings per share. On average, equities analysts forecast that Varian Medical Systems, Inc. will post $3.95 EPS for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This story was reported by BBNS and is the property of of BBNS. If you are reading this story on another domain, it was illegally copied and republished in violation of US & international copyright laws. The original version of this story can be read at https://baseballnewssource.com/markets/insider-selling-varian-medical-systems-inc-nysevar-evp-sells-1088-shares-of-stock-updated-updated-updated/1199603.html.

Large investors have recently added to or reduced their stakes in the company. Vident Investment Advisory LLC boosted its stake in Varian Medical Systems by 42.5% in the fourth quarter. Vident Investment Advisory LLC now owns 14,681 shares of the medical equipment provider’s stock valued at $1,318,000 after buying an additional 4,381 shares during the last quarter. California Public Employees Retirement System boosted its stake in Varian Medical Systems by 3.3% in the first quarter. California Public Employees Retirement System now owns 250,600 shares of the medical equipment provider’s stock valued at $22,837,000 after buying an additional 8,100 shares during the last quarter. Hussman Strategic Advisors Inc. boosted its stake in Varian Medical Systems by 9.0% in the first quarter. Hussman Strategic Advisors Inc. now owns 10,900 shares of the medical equipment provider’s stock valued at $993,000 after buying an additional 900 shares during the last quarter. Bank of America Corp DE boosted its stake in Varian Medical Systems by 4.6% in the first quarter. Bank of America Corp DE now owns 1,992,821 shares of the medical equipment provider’s stock valued at $181,605,000 after buying an additional 87,522 shares during the last quarter. Finally, Teachers Advisors LLC boosted its stake in Varian Medical Systems by 3.9% in the fourth quarter. Teachers Advisors LLC now owns 107,778 shares of the medical equipment provider’s stock valued at $9,676,000 after buying an additional 4,000 shares during the last quarter. Hedge funds and other institutional investors own 99.27% of the company’s stock.

Several analysts have commented on the company. BidaskClub lowered Varian Medical Systems from a “hold” rating to a “sell” rating in a research report on Thursday, August 3rd. Robert W. Baird reissued a “neutral” rating and set a $99.00 price target (up from $89.00) on shares of Varian Medical Systems in a research report on Friday, July 14th. Zacks Investment Research lowered Varian Medical Systems from a “buy” rating to a “hold” rating in a research report on Thursday, July 13th. Aegis reissued a “hold” rating and set a $91.00 price target on shares of Varian Medical Systems in a research report on Wednesday, May 17th. Finally, Goldman Sachs Group, Inc. (The) assumed coverage on Varian Medical Systems in a research report on Tuesday, May 16th. They issued a “neutral” rating and a $92.00 target price on the stock. Three research analysts have rated the stock with a sell rating, six have issued a hold rating and three have issued a buy rating to the stock. Varian Medical Systems currently has a consensus rating of “Hold” and a consensus target price of $96.28.

About Varian Medical Systems

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Insider Buying and Selling by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems Inc. and related companies with our FREE daily email newsletter.

 


Latest News

Despite Changes to Reduce The Length of Games, MLB Games are Actually Getting Longer
Despite Changes to Reduce The Length of Games, MLB Games are Actually Getting Longer
Despite Hitting Home Run, Judge Sets Longest Game Streak for Strikeouts
Despite Hitting Home Run, Judge Sets Longest Game Streak for Strikeouts
Los Angeles Dodgers Move 50 Games Over .500
Los Angeles Dodgers Move 50 Games Over .500
Miami’s Giancarlo Stanton Sets Marlins Home Run Record
Miami’s Giancarlo Stanton Sets Marlins Home Run Record
Bryce Harper Latest Star to Suffer Injury
Bryce Harper Latest Star to Suffer Injury
Chicago Cubs Must Survive Without Willson Contreras
Chicago Cubs Must Survive Without Willson Contreras


Leave a Reply

 
© 2006-2017 BBNS.